CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-06 | O'Brien Patrick General Counsel | Sale | −100 | $61.02 | $6K | 258,375 |
| 2020-01-06 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −7,593 | $59.60 | $453K | 403,592 |
| 2020-01-06 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −11,907 | $60.40 | $719K | 391,685 |
| 2020-01-06 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −500 | $60.95 | $30K | 391,185 |
| 2020-01-01 | De Backer Marianne Director | Grant or award | +7,500 | 12,500 | ||
| 2020-01-01 | PERRY MICHAEL S Director | Grant or award | +8,000 | 44,000 | ||
| 2020-01-01 | Waddill William D. Director | Grant or award | +7,500 | 54,000 | ||
| 2020-01-01 | GIVEN BRUCE D Chief Operating Officer | Grant or award | +250,000 | 894,606 | ||
| 2020-01-01 | O'Brien Patrick General Counsel | Grant or award | +70,000 | 273,000 | ||
| 2020-01-01 | Anzalone Christopher Richard Chief Executive Officer | Grant or award | +900,000 | 2,705,237 | ||
| 2020-01-01 | Myszkowski Kenneth Allen Chief Financial Officer | Grant or award | +85,000 | 411,185 | ||
| 2020-01-01 | Ferrari Mauro Director | Grant or award | +7,500 | 14,400 | ||
| 2020-01-01 | GIVEN DOUGLAS B Director | Grant or award | +8,000 | 180,925 | ||
| 2019-12-24 | Anzalone Christopher Richard Chief Executive Officer | Sale | −83,333 | $63.50 | $5.3M | 1,805,237 |
| 2019-12-13 | Anzalone Christopher Richard Chief Executive Officer | Sale | −8,951 | $65.85 | $589K | 1,962,952 |
| 2019-12-13 | Anzalone Christopher Richard Chief Executive Officer | Sale | −45,577 | $66.47 | $3.0M | 1,917,375 |
| 2019-12-13 | Anzalone Christopher Richard Chief Executive Officer | Sale | −25,412 | $67.30 | $1.7M | 1,891,963 |
| 2019-12-13 | Anzalone Christopher Richard Chief Executive Officer | Sale | −3,393 | $68.18 | $231K | 1,888,570 |
| 2019-12-12 | Anzalone Christopher Richard Chief Executive Officer | Sale | −23,219 | $66.82 | $1.6M | 2,048,684 |
| 2019-12-12 | Anzalone Christopher Richard Chief Executive Officer | Sale | −58,059 | $67.31 | $3.9M | 1,990,625 |
Page 27 of 38 · 752 trades